New data on hemoadsorption with CytoSorb Therapy
- COVID-19, ECMO, Intensive Care, Liver
e-ISICEM 2020
Satellite Meeting | Wednesday, September 16th 2020
New data on hemoadsorption with CytoSorb Therapy in critically ill patients
Chair: J Kellum, Pittsburgh, USA
- Inflammation and intervention in COVID-19 patients – A summary of actual results
A Nierhaus, Hamburg, Germany - Progress in short- and long-term survival of septic shock patients
C Ince, Rotterdam, The Netherlands - ECMO in combination with hemoadsorption – What are the benefits
A Supady, Freiburg, Germany - New liver support therapy – Detoxification and reduction of hyperinflammation in one step
I Riva, Bergamo, Italy
Share
|
New data on hemoadsorption with CytoSorb Therapy
- July 27, 2020
- COVID-19, ECMO, Intensive Care, Liver
Share
|
e-ISICEM 2020
Satellite Meeting | Wednesday, September 16th 2020
New data on hemoadsorption with CytoSorb Therapy in critically ill patients
Chair: J Kellum, Pittsburgh, USA
- Inflammation and intervention in COVID-19 patients – A summary of actual results
A Nierhaus, Hamburg, Germany - Progress in short- and long-term survival of septic shock patients
C Ince, Rotterdam, The Netherlands - ECMO in combination with hemoadsorption – What are the benefits
A Supady, Freiburg, Germany - New liver support therapy – Detoxification and reduction of hyperinflammation in one step
I Riva, Bergamo, Italy
More Videos
Future – What do you think about the future of CytoSorb?
Safety – How would you describe the safety profile of CytoSorb?
Ease of use – How easy is the set-up of CytoSorb?
Clinical effects – What are the most impressive clinical effects when you use CytoSorb?
CytoSorb Testimonials
Early use – When should CytoSorb be started in septic shock?